• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的症状学和症状治疗:来自全国多发性硬化症登记处的结果。

Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry.

机构信息

Department of Neurology, Neuroimmunological Section, University of Rostock, Rostock, Germany/Department of Neurology, Medical University of Vienna, Vienna, Austria.

MS Forschungs- und Projektentwicklungs-gGmbH, Hannover, Germany.

出版信息

Mult Scler. 2019 Oct;25(12):1641-1652. doi: 10.1177/1352458518799580. Epub 2018 Sep 19.

DOI:10.1177/1352458518799580
PMID:30230952
Abstract

BACKGROUND

Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease. Over time, symptoms accumulate leading to increased disability of patients.

OBJECTIVE

The objective of this article is to analyze the prevalence of symptoms and symptomatic treatment patterns in a nationwide MS registry.

METHODS

Data sets from 35,755 patients were analyzed.

RESULTS

More than two-thirds of patients were women with a mean age of 46.1 (±12.8) years. Median Expanded Disability Status Score (EDSS) was 3.0. The most frequently reported symptoms were fatigue, spasticity, and voiding disorders. In patients with short disease duration, fatigue was reported most frequently. Symptomatic treatment was most common for spasticity and depression, whereas fatigue was treated only in a third of affected patients. Almost a fifth of patients with EDSS ⩽ 3.5 and neuropsychological symptoms had retired from work.

CONCLUSION

Whereas treatment for spasticity and depression is common in our cohort, sexual dysfunction, dysphagia, cognitive dysfunction, and fatigue are treated to a far lesser extent. The need for psychological support, physical, and occupational therapy has to be recognized as neuropsychological symptoms have a great impact on retirement at an early stage. Overall symptomatic treatment rates for the most common symptoms have increased over the last years ( < 0.001).

摘要

背景

多发性硬化症(MS)是一种神经炎症和神经退行性疾病。随着时间的推移,症状不断积累,导致患者的残疾程度增加。

目的

本文旨在分析全国多发性硬化症登记处的症状发生率和对症治疗模式。

方法

分析了 35755 名患者的数据组。

结果

超过三分之二的患者为女性,平均年龄为 46.1(±12.8)岁。扩展残疾状态评分(EDSS)中位数为 3.0。报告最多的症状是疲劳、痉挛和排尿障碍。在疾病持续时间较短的患者中,疲劳的报告最为频繁。痉挛和抑郁的对症治疗最为常见,而疲劳仅在三分之一的受影响患者中得到治疗。近五分之一 EDSS ⩽ 3.5 且有神经心理症状的患者已退休。

结论

尽管我们的队列中常见痉挛和抑郁的治疗,但性功能障碍、吞咽困难、认知功能障碍和疲劳的治疗程度要低得多。需要认识到心理支持、身体和职业治疗的必要性,因为神经心理症状会在早期对退休产生重大影响。过去几年,最常见症状的总体对症治疗率有所增加(<0.001)。

相似文献

1
Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry.多发性硬化症的症状学和症状治疗:来自全国多发性硬化症登记处的结果。
Mult Scler. 2019 Oct;25(12):1641-1652. doi: 10.1177/1352458518799580. Epub 2018 Sep 19.
2
Managing the symptoms of multiple sclerosis: a multimodal approach.多发性硬化症症状的管理:一种多模式方法。
Clin Ther. 2006 Apr;28(4):445-60. doi: 10.1016/j.clinthera.2006.04.005.
3
Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.多发性硬化症的对症治疗——一项全国性登记研究的中期分析
Acta Neurol Scand. 2017 Apr;135(4):394-399. doi: 10.1111/ane.12612. Epub 2016 Jun 9.
4
Need for symptomatic management in advanced multiple sclerosis.
Acta Neurol Scand. 2017 May;135(5):529-532. doi: 10.1111/ane.12631. Epub 2016 Jun 29.
5
A multimodal approach to managing the symptoms of multiple sclerosis.一种管理多发性硬化症症状的多模式方法。
Neurology. 2004 Dec 14;63(11 Suppl 5):S12-8. doi: 10.1212/wnl.63.11_suppl_5.s12.
6
Symptomatic therapy of multiple sclerosis.多发性硬化症的症状性治疗。
Curr Opin Neurol. 1994 Jun;7(3):229-33. doi: 10.1097/00019052-199406000-00009.
7
Symptomatic treatment and management of multiple sclerosis.多发性硬化症的对症治疗与管理
Handb Clin Neurol. 2014;122:513-62. doi: 10.1016/B978-0-444-52001-2.00023-6.
8
The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey.多发性硬化症相关症状与残疾和生活质量的关联:一项丹麦大型自我报告调查。
BMC Neurol. 2021 Aug 16;21(1):317. doi: 10.1186/s12883-021-02344-z.
9
Symptomatic management in multiple sclerosis.多发性硬化的症状管理。
Neurol Clin. 2011 May;29(2):449-63. doi: 10.1016/j.ncl.2011.01.008.
10
Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.复发缓解型和进展型多发性硬化症患者生活质量的决定因素。
Mult Scler Relat Disord. 2019 May;30:33-37. doi: 10.1016/j.msard.2019.01.049. Epub 2019 Jan 30.

引用本文的文献

1
Discrepancy Between Vaccination Willingness and Actual SARS-CoV-2 Vaccination Status in People with Multiple Sclerosis: A Longitudinal Study.多发性硬化症患者接种意愿与实际新冠病毒疫苗接种状况的差异:一项纵向研究
J Clin Med. 2025 May 24;14(11):3689. doi: 10.3390/jcm14113689.
2
Clinical and paraclinical features distinguish fatigue from depression-predominant phenotypes in multiple sclerosis.临床和副临床特征可区分多发性硬化症中以疲劳为主与以抑郁为主的表型。
Sci Rep. 2025 May 21;15(1):17718. doi: 10.1038/s41598-025-03079-4.
3
Trauma Burden Affected People with Multiple Sclerosis During SARS-CoV-2 Pandemic.
在新冠疫情期间,创伤负担影响了多发性硬化症患者。
J Clin Med. 2025 Apr 13;14(8):2665. doi: 10.3390/jcm14082665.
4
Internet-based exercise and physical activity promotion for persons with multiple sclerosis: a randomized controlled trial.基于互联网的多发性硬化症患者运动与身体活动促进:一项随机对照试验。
BMC Sports Sci Med Rehabil. 2025 Apr 23;17(1):90. doi: 10.1186/s13102-025-01146-x.
5
Towards developing brain-computer interfaces for people with Multiple Sclerosis.致力于为多发性硬化症患者开发脑机接口。
PLoS One. 2025 Mar 18;20(3):e0319811. doi: 10.1371/journal.pone.0319811. eCollection 2025.
6
Investigating mechanisms underlying the development of paralysis symptom in a model of MS.在多发性硬化症模型中研究瘫痪症状发展的潜在机制。
Brain Res Bull. 2025 Apr;223:111275. doi: 10.1016/j.brainresbull.2025.111275. Epub 2025 Feb 26.
7
Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators.用于治疗多发性硬化症和视神经脊髓炎谱系障碍复发的单采术:抗体反应性降低、基因表达变化及潜在临床反应指标
Front Immunol. 2025 Jan 30;16:1531447. doi: 10.3389/fimmu.2025.1531447. eCollection 2025.
8
Promotes Antioxidant Gene Expression and Mitochondrial Oxidative Respiration in Experimental Autoimmune Encephalomyelitis.在实验性自身免疫性脑脊髓炎中促进抗氧化基因表达和线粒体氧化呼吸。
Pharmaceuticals (Basel). 2024 Dec 13;17(12):1681. doi: 10.3390/ph17121681.
9
Best supportive care for patients with primary progressive multiple sclerosis (PPMS) in Germany prior to ocrelizumab treatment: Final results from the RETRO PPMS study.德国在使用奥瑞珠单抗治疗原发性进行性多发性硬化症(PPMS)患者之前的最佳支持性护理:RETRO PPMS研究的最终结果。
J Cent Nerv Syst Dis. 2024 Oct 23;16:11795735241296001. doi: 10.1177/11795735241296001. eCollection 2024.
10
Personality traits in patients with multiple sclerosis: their association with nicotine dependence and polypharmacy.多发性硬化症患者的人格特质:它们与尼古丁依赖和多种药物治疗的关联。
Ther Adv Neurol Disord. 2024 Oct 14;17:17562864241279118. doi: 10.1177/17562864241279118. eCollection 2024.